| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.689 | 0.012 | 0.689 | Antiobesity | 0.646 0.015 CHEMBL3526890 0.231 0.176 CHEMBL3526548 0.317 0.105 CHEMBL3526891 0.238 0.169 CHEMBL3527277 0.37 0.078 CHEMBL3527211 0.278 0.133 CHEMBL3527278 0.417 0.059 CHEMBL3526547 | ||
| 0.657 | 0.002 | 0.657 | Cannabinoid CB1 receptor antagonist | 0.455 0.003 CHEMBL3526890 0.143 0.008 CHEMBL3526891 0.187 0.005 CHEMBL3527277 0.101 0.016 CHEMBL3527278 0.292 0.004 CHEMBL3526547 | ||
| 0.632 | 0.003 | 0.632 | Cannabinoid receptor antagonist | 0.399 0.004 CHEMBL3526890 0.14 0.016 CHEMBL3526891 0.152 0.014 CHEMBL3527277 0.086 0.036 CHEMBL3527278 0.278 0.005 CHEMBL3526547 | ||
| 0.406 | 0.055 | 0.406 | MAP kinase kinase 6 inhibitor | 0.372 0.076 CHEMBL3526890 0.229 0.22 CHEMBL3526548 0.278 0.158 CHEMBL3526891 0.284 0.151 CHEMBL3527277 0.249 0.191 CHEMBL3527278 0.386 0.067 CHEMBL3526547 | ||
| 0.371 | 0.108 | 0.562 | Cyclophilin D inhibitor | 0.301 0.162 CHEMBL3526890 0.521 0.044 CHEMBL3526548 0.245 0.218 CHEMBL3526891 0.562 0.035 CHEMBL3527211 | CHEMBL3527211 | |
| 0.259 | 0.018 | 0.359 | Ribosomal protein S6 kinase inhibitor | 0.359 0.006 CHEMBL3526890 0.125 0.085 CHEMBL3526548 0.277 0.015 CHEMBL3526891 0.238 0.024 CHEMBL3527277 0.142 0.071 CHEMBL3527211 0.347 0.007 CHEMBL3527278 0.296 0.012 CHEMBL3526547 | CHEMBL3526890 | |
| 0.242 | 0.005 | 0.565 | Protein kinase B gamma inhibitor | 0.565 0.003 CHEMBL3526890 0.123 0.024 CHEMBL3526548 0.28 0.005 CHEMBL3526891 0.191 0.009 CHEMBL3527277 0.083 0.044 CHEMBL3527211 0.145 0.017 CHEMBL3527278 0.195 0.008 CHEMBL3526547 | CHEMBL3526890 | |
| 0.224 | 0.004 | 0.332 | Phosphodiesterase II inhibitor | 0.273 0.004 CHEMBL3526890 0.133 0.006 CHEMBL3526548 0.261 0.004 CHEMBL3526891 0.217 0.004 CHEMBL3527277 0.106 0.01 CHEMBL3527211 0.294 0.003 CHEMBL3527278 0.332 0.003 CHEMBL3526547 | CHEMBL3526547 | |
| 0.212 | 0.004 | 0.321 | Phosphodiesterase 2A inhibitor | 0.262 0.004 CHEMBL3526890 0.124 0.006 CHEMBL3526548 0.249 0.004 CHEMBL3526891 0.206 0.004 CHEMBL3527277 0.097 0.009 CHEMBL3527211 0.283 0.003 CHEMBL3527278 0.321 0.003 CHEMBL3526547 | CHEMBL3526547 | |
| 0.2 | 0.005 | 0.445 | Protein kinase B alpha inhibitor | 0.445 0.003 CHEMBL3526890 0.135 0.013 CHEMBL3526548 0.257 0.004 CHEMBL3526891 0.189 0.005 CHEMBL3527277 0.104 0.028 CHEMBL3527211 0.162 0.006 CHEMBL3527278 0.193 0.005 CHEMBL3526547 | CHEMBL3526890 | |
| 0.249 | 0.067 | 0.431 | HERG channel blocker | 0.431 0.023 CHEMBL3526890 | CHEMBL3526890 | |
| 0.181 | 0.005 | 0.414 | Protein kinase B beta inhibitor | 0.414 0.003 CHEMBL3526890 0.108 0.021 CHEMBL3526548 0.287 0.004 CHEMBL3526891 0.178 0.005 CHEMBL3527277 0.094 0.03 CHEMBL3527211 0.127 0.013 CHEMBL3527278 0.154 0.007 CHEMBL3526547 | CHEMBL3526890 | |
| 0.308 | 0.135 | 0.461 | Analgesic | 0.274 0.163 CHEMBL3526890 0.461 0.061 CHEMBL3526891 | CHEMBL3526891 | |
| 0.227 | 0.061 | 0.247 | MAP kinase kinase 3 inhibitor | 0.247 0.034 CHEMBL3526890 0.19 0.155 CHEMBL3526548 0.218 0.077 CHEMBL3527277 0.192 0.148 CHEMBL3526547 | CHEMBL3526890 | |
| 0.328 | 0.177 | 0.442 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.344 0.157 CHEMBL3526890 0.354 0.146 CHEMBL3526891 0.373 0.126 CHEMBL3527278 0.442 0.067 CHEMBL3526547 | CHEMBL3526547 | |
| 0.201 | 0.062 | 0.314 | LIM domain kinase 1 inhibitor | 0.314 0.018 CHEMBL3526890 0.176 0.076 CHEMBL3526891 0.139 0.11 CHEMBL3526547 | CHEMBL3526890 | |
| 0.14 | 0.004 | 0.14 | Corticotropin releasing factor 2 receptor antagonist | 0.107 0.005 CHEMBL3526890 0.066 0.034 CHEMBL3526891 0.071 0.027 CHEMBL3527277 0.082 0.016 CHEMBL3527278 0.128 0.004 CHEMBL3526547 | ||
| 0.229 | 0.097 | 0.25 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.25 0.065 CHEMBL3526890 0.227 0.102 CHEMBL3526548 0.219 0.118 CHEMBL3526891 0.216 0.124 CHEMBL3527277 0.208 0.144 CHEMBL3527278 0.246 0.071 CHEMBL3526547 | CHEMBL3526890 | |
| 0.209 | 0.08 | 0.289 | ErbB-1 antagonist | 0.214 0.076 CHEMBL3526890 0.209 0.08 CHEMBL3526891 0.17 0.132 CHEMBL3527277 0.22 0.07 CHEMBL3527278 0.289 0.036 CHEMBL3526547 | CHEMBL3526547 | |
| 0.146 | 0.027 | 0.221 | Multidrug resistance-associated protein 1 inhibitor | 0.166 0.019 CHEMBL3526890 0.096 0.086 CHEMBL3526548 0.161 0.021 CHEMBL3526891 0.13 0.038 CHEMBL3527277 0.122 0.046 CHEMBL3527211 0.186 0.014 CHEMBL3527278 0.221 0.007 CHEMBL3526547 | CHEMBL3526547 | |
| 0.124 | 0.018 | 0.171 | Phosphodiesterase XI inhibitor | 0.14 0.013 CHEMBL3526890 0.102 0.03 CHEMBL3526891 0.109 0.025 CHEMBL3527277 0.126 0.018 CHEMBL3527278 0.171 0.007 CHEMBL3526547 | CHEMBL3526547 | |
| 0.124 | 0.018 | 0.171 | Phosphodiesterase 11A inhibitor | 0.14 0.013 CHEMBL3526890 0.102 0.03 CHEMBL3526891 0.109 0.025 CHEMBL3527277 0.126 0.018 CHEMBL3527278 0.171 0.007 CHEMBL3526547 | CHEMBL3526547 | |
| 0.199 | 0.097 | 0.368 | Potassium channel (Voltage-sensitive) blocker | 0.368 0.033 CHEMBL3526890 | CHEMBL3526890 | |
| 0.155 | 0.053 | 0.161 | MAP kinase kinase 4 inhibitor | 0.154 0.054 CHEMBL3526890 0.133 0.104 CHEMBL3526548 0.147 0.067 CHEMBL3526891 0.136 0.096 CHEMBL3527277 0.133 0.105 CHEMBL3527278 0.161 0.044 CHEMBL3526547 | CHEMBL3526547 | |
| 0.099 | 0.004 | 0.248 | LIM domain kinase 2 inhibitor | 0.248 0.002 CHEMBL3526890 0.04 0.01 CHEMBL3526548 0.132 0.004 CHEMBL3526891 0.085 0.004 CHEMBL3527277 0.035 0.014 CHEMBL3527211 0.041 0.009 CHEMBL3527278 0.056 0.005 CHEMBL3526547 | CHEMBL3526890 | |
| 0.195 | 0.11 | 0.217 | MAP-kinase-activated kinase 5 inhibitor | 0.217 0.085 CHEMBL3526890 0.167 0.154 CHEMBL3527277 0.206 0.096 CHEMBL3526547 | CHEMBL3526890 | |
| 0.141 | 0.057 | 0.18 | MAP kinase kinase inhibitor | 0.125 0.069 CHEMBL3526890 0.18 0.036 CHEMBL3527277 0.107 0.087 CHEMBL3526547 | CHEMBL3527277 | |
| 0.1 | 0.025 | 0.387 | Benzodiazepine agonist | 0.114 0.019 CHEMBL3526890 0.087 0.034 CHEMBL3526891 0.067 0.056 CHEMBL3527277 0.137 0.01 CHEMBL3527278 0.387 0.003 CHEMBL3526547 | CHEMBL3526547 | |
| 0.109 | 0.04 | 0.23 | Protein kinase A inhibitor | 0.23 0.01 CHEMBL3526890 0.098 0.047 CHEMBL3526891 0.081 0.059 CHEMBL3527277 | CHEMBL3526890 | |
| 0.093 | 0.026 | 0.226 | Protein kinase C alpha inhibitor | 0.226 0.005 CHEMBL3526890 0.106 0.02 CHEMBL3526548 0.167 0.008 CHEMBL3526891 0.076 0.037 CHEMBL3527277 0.075 0.038 CHEMBL3527211 | CHEMBL3526890 | |
| 0.14 | 0.084 | 0.237 | MAP kinase 3 inhibitor | 0.144 0.078 CHEMBL3526890 0.13 0.107 CHEMBL3526891 0.202 0.023 CHEMBL3527277 0.237 0.011 CHEMBL3527278 0.162 0.051 CHEMBL3526547 | CHEMBL3527278 | |
| 0.166 | 0.11 | 0.429 | Anticonvulsant | 0.158 0.12 CHEMBL3526890 0.159 0.118 CHEMBL3526548 0.429 0.019 CHEMBL3526891 0.162 0.115 CHEMBL3527278 0.364 0.027 CHEMBL3526547 | CHEMBL3526891 | |
| 0.17 | 0.115 | 0.281 | Potassium channel blocker | 0.281 0.053 CHEMBL3526890 0.166 0.119 CHEMBL3526547 | CHEMBL3526890 | |
| 0.081 | 0.028 | 0.081 | Cannabinoid CB1 receptor agonist | |||
| 0.101 | 0.056 | 0.129 | Protein kinase C mu inhibitor | 0.129 0.037 CHEMBL3526890 0.085 0.073 CHEMBL3526891 | CHEMBL3526890 | |
| 0.113 | 0.074 | 0.175 | Transcription factor STAT6 inhibitor | 0.13 0.044 CHEMBL3526890 0.109 0.083 CHEMBL3526548 0.164 0.015 CHEMBL3527277 0.107 0.088 CHEMBL3527211 0.175 0.011 CHEMBL3527278 0.141 0.031 CHEMBL3526547 | CHEMBL3527278 | |
| 0.201 | 0.163 | 0.391 | Immunomodulator | 0.289 0.088 CHEMBL3526890 0.319 0.072 CHEMBL3526548 0.308 0.078 CHEMBL3526891 0.391 0.047 CHEMBL3527211 | CHEMBL3527211 | |
| 0.158 | 0.121 | 0.161 | MAP kinase kinase 5 inhibitor | 0.161 0.111 CHEMBL3526890 | CHEMBL3526890 | |
| 0.059 | 0.021 | 0.242 | Phosphodiesterase X inhibitor | 0.078 0.014 CHEMBL3526890 0.07 0.016 CHEMBL3526891 0.046 0.03 CHEMBL3527277 0.114 0.009 CHEMBL3527278 0.242 0.004 CHEMBL3526547 | CHEMBL3526547 | |
| 0.059 | 0.021 | 0.242 | Phosphodiesterase 10A inhibitor | 0.078 0.014 CHEMBL3526890 0.07 0.016 CHEMBL3526891 0.046 0.03 CHEMBL3527277 0.114 0.009 CHEMBL3527278 0.242 0.004 CHEMBL3526547 | CHEMBL3526547 | |
| 0.071 | 0.034 | 0.098 | Phosphodiesterase VII inhibitor | 0.08 0.026 CHEMBL3526890 0.075 0.03 CHEMBL3526891 0.061 0.045 CHEMBL3527278 0.098 0.013 CHEMBL3526547 | CHEMBL3526547 | |
| 0.12 | 0.082 | 0.434 | Phosphodiesterase inhibitor | 0.155 0.055 CHEMBL3526890 0.141 0.064 CHEMBL3526891 0.137 0.067 CHEMBL3527277 0.258 0.021 CHEMBL3527278 0.434 0.005 CHEMBL3526547 | CHEMBL3526547 | |
| 0.13 | 0.098 | 0.282 | Heat shock protein 90 antagonist | 0.127 0.101 CHEMBL3526890 0.175 0.052 CHEMBL3527277 0.282 0.013 CHEMBL3527278 0.174 0.053 CHEMBL3526547 | CHEMBL3527278 | |
| 0.064 | 0.036 | 0.064 | Bombesin 1 receptor agonist | |||
| 0.097 | 0.07 | 0.189 | Hedgehog signaling inhibitor | 0.109 0.051 CHEMBL3526890 0.094 0.075 CHEMBL3526891 0.109 0.052 CHEMBL3527278 0.189 0.013 CHEMBL3526547 | CHEMBL3526547 | |
| 0.048 | 0.023 | 0.056 | Dipeptidyl peptidase IV inhibitor | 0.056 0.015 CHEMBL3526890 | CHEMBL3526890 | |
| 0.095 | 0.07 | 0.139 | Check point kinase 2 inhibitor | 0.139 0.036 CHEMBL3526890 0.089 0.075 CHEMBL3527277 0.106 0.06 CHEMBL3527278 | CHEMBL3526890 | |
| 0.082 | 0.058 | 0.095 | Transforming growth factor beta 3 antagonist | 0.093 0.033 CHEMBL3526890 0.078 0.07 CHEMBL3526891 0.078 0.072 CHEMBL3527277 0.078 0.072 CHEMBL3527278 0.095 0.03 CHEMBL3526547 | CHEMBL3526547 | |
| 0.062 | 0.039 | 0.128 | Phosphatidylinositol kinase inhibitor | 0.088 0.025 CHEMBL3526890 0.052 0.051 CHEMBL3526891 0.052 0.051 CHEMBL3527278 0.128 0.015 CHEMBL3526547 | CHEMBL3526547 | |
| 0.077 | 0.055 | 0.11 | MAP kinase kinase 7 inhibitor | 0.089 0.026 CHEMBL3526890 0.084 0.035 CHEMBL3526891 0.11 0.006 CHEMBL3526547 | CHEMBL3526547 | |
| 0.155 | 0.137 | 0.181 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.181 0.107 CHEMBL3526890 | CHEMBL3526890 | |
| 0.044 | 0.027 | 0.085 | GHS receptor agonist | 0.085 0.006 CHEMBL3526890 | CHEMBL3526890 | |
| 0.052 | 0.038 | 0.085 | Dipeptidyl peptidase inhibitor | 0.085 0.012 CHEMBL3526890 | CHEMBL3526890 | |
| 0.145 | 0.134 | 0.205 | EphB2 antagonist | 0.189 0.095 CHEMBL3526890 0.148 0.131 CHEMBL3526891 0.146 0.134 CHEMBL3527278 0.205 0.085 CHEMBL3526547 | CHEMBL3526547 | |
| 0.054 | 0.043 | 0.115 | Phosphatidylinositol 3-kinase delta inhibitor | 0.086 0.023 CHEMBL3526890 0.052 0.045 CHEMBL3526891 0.049 0.047 CHEMBL3527278 0.115 0.017 CHEMBL3526547 | CHEMBL3526547 | |
| 0.072 | 0.066 | 0.148 | Platelet growth factor antagonist | 0.071 0.067 CHEMBL3526890 0.071 0.067 CHEMBL3527277 0.148 0.02 CHEMBL3526547 | CHEMBL3526547 | |
| 0.01 | 0.005 | 0.028 | Corticotropin releasing factor antagonist | 0.01 0.005 CHEMBL3527278 0.028 0.003 CHEMBL3526547 | CHEMBL3526547 | |
| 0.183 | 0.179 | 0.183 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.048 | 0.045 | 0.059 | Phosphodiesterase 7A inhibitor | 0.051 0.039 CHEMBL3526890 0.059 0.023 CHEMBL3526547 | CHEMBL3526547 | |
| 0.046 | 0.054 | 0.056 | 5 Hydroxytryptamine 3 antagonist | 0.056 0.041 CHEMBL3526890 0.056 0.04 CHEMBL3526547 | CHEMBL3526547 | |
| 0.013 | 0.024 | 0.017 | Adenosine A3 receptor agonist | 0.017 0.012 CHEMBL3526548 0.017 0.012 CHEMBL3527211 | CHEMBL3527211 | |
| 0.016 | 0.027 | 0.021 | Corticotropin releasing factor 1 receptor antagonist | 0.021 0.017 CHEMBL3526547 | CHEMBL3526547 | |
| 0.023 | 0.035 | 0.027 | Purinergic P2Y15 antagonist | 0.027 0.024 CHEMBL3526890 0.027 0.023 CHEMBL3527277 | CHEMBL3527277 | |
| 0.094 | 0.108 | 0.124 | Epidermal growth factor receptor kinase inhibitor | 0.104 0.092 CHEMBL3526890 0.118 0.074 CHEMBL3527278 0.124 0.069 CHEMBL3526547 | CHEMBL3526547 | |
| 0.025 | 0.041 | 0.046 | Phosphoglycerate kinase inhibitor | 0.046 0.016 CHEMBL3526548 | CHEMBL3526548 | |
| 0.037 | 0.053 | 0.084 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.051 0.036 CHEMBL3526890 0.084 0.02 CHEMBL3526547 | CHEMBL3526547 | |
| 0.015 | 0.032 | 0.034 | Adenosine A1 receptor agonist | 0.034 0.01 CHEMBL3526548 0.031 0.011 CHEMBL3527211 | CHEMBL3526548 | |
| 0.025 | 0.045 | 0.033 | Potassium channel (Inward rectifier) 1 blocker | 0.033 0.014 CHEMBL3526547 | CHEMBL3526547 | |
| 0.04 | 0.061 | 0.128 | Adenosine A1 receptor antagonist | 0.102 0.023 CHEMBL3526548 0.128 0.018 CHEMBL3526547 | CHEMBL3526547 | |
| 0.063 | 0.087 | 0.176 | Phosphodiesterase 3A inhibitor | 0.074 0.065 CHEMBL3526890 0.085 0.048 CHEMBL3527278 0.176 0.011 CHEMBL3526547 | CHEMBL3526547 | |
| 0.038 | 0.063 | 0.053 | Histamine H4 receptor antagonist | 0.053 0.026 CHEMBL3526547 | CHEMBL3526547 | |
| 0.011 | 0.04 | 0.21 | Adenosine kinase inhibitor | 0.023 0.014 CHEMBL3526890 0.21 0.002 CHEMBL3526548 0.026 0.012 CHEMBL3526891 0.03 0.01 CHEMBL3527211 0.04 0.007 CHEMBL3527278 0.037 0.008 CHEMBL3526547 | CHEMBL3526548 | |
| 0.081 | 0.113 | 0.126 | mTOR complex 1 inhibitor | 0.126 0.023 CHEMBL3526547 | CHEMBL3526547 | |
| 0.028 | 0.06 | 0.053 | Nicotinic acid receptor 1 agonist | 0.053 0.019 CHEMBL3526891 0.049 0.021 CHEMBL3526547 | CHEMBL3526891 | |
| 0.057 | 0.09 | 0.093 | Adenosine A3 receptor antagonist | 0.093 0.03 CHEMBL3526548 0.074 0.052 CHEMBL3526547 | CHEMBL3526548 | |
| 0.031 | 0.064 | 0.138 | Phosphodiesterase 4A inhibitor | 0.046 0.037 CHEMBL3527277 0.048 0.036 CHEMBL3527278 0.138 0.011 CHEMBL3526547 | CHEMBL3526547 | |
| 0.009 | 0.043 | 0.013 | Adenosine A2b receptor agonist | 0.013 0.012 CHEMBL3526548 | CHEMBL3526548 | |
| 0.11 | 0.152 | 0.275 | Death-associated protein kinase 1 inhibitor | 0.123 0.104 CHEMBL3527277 0.275 0.004 CHEMBL3527278 0.126 0.092 CHEMBL3526547 | CHEMBL3527278 | |
| 0.07 | 0.112 | 0.105 | Phosphodiesterase 7B inhibitor | 0.091 0.068 CHEMBL3526890 0.102 0.054 CHEMBL3526891 0.105 0.051 CHEMBL3526547 | CHEMBL3526547 | |
| 0.154 | 0.197 | 0.197 | 5 Hydroxytryptamine 3E antagonist | 0.197 0.068 CHEMBL3526547 | CHEMBL3526547 | |
| 0.043 | 0.086 | 0.068 | 5 Hydroxytryptamine 3A antagonist | 0.068 0.044 CHEMBL3526547 | CHEMBL3526547 | |
| 0.066 | 0.11 | 0.104 | Aminoacyl-tRNA synthetase inhibitor | 0.104 0.041 CHEMBL3526548 0.085 0.067 CHEMBL3526891 0.085 0.068 CHEMBL3527211 | CHEMBL3526548 | |
| 0.151 | 0.198 | 0.231 | RNA-directed DNA polymerase inhibitor | 0.231 0.063 CHEMBL3526548 0.192 0.113 CHEMBL3526891 0.222 0.072 CHEMBL3527211 0.207 0.09 CHEMBL3526547 | CHEMBL3526548 | |
| 0.011 | 0.059 | 0.023 | Purinergic P2X agonist | 0.023 0.022 CHEMBL3526548 | CHEMBL3526548 | |
| 0.016 | 0.064 | 0.097 | Potassium channel small-conductance Ca-activated activator | 0.029 0.025 CHEMBL3526890 0.097 0.004 CHEMBL3527278 0.042 0.014 CHEMBL3526547 | CHEMBL3527278 | |
| 0.054 | 0.104 | 0.07 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.07 0.068 CHEMBL3526890 0.07 0.069 CHEMBL3526547 | CHEMBL3526547 | |
| 0.156 | 0.21 | 0.378 | Hypoxia-inducible factor 1 alpha inhibitor | 0.184 0.173 CHEMBL3526891 0.235 0.114 CHEMBL3527211 0.261 0.091 CHEMBL3527278 0.378 0.036 CHEMBL3526547 | CHEMBL3526547 | |
| 0.075 | 0.129 | 0.115 | Protein-tyrosine kinase Lyn inhibitor | 0.106 0.096 CHEMBL3526890 0.115 0.089 CHEMBL3526547 | CHEMBL3526547 | |
| 0.033 | 0.091 | 0.074 | Adenosine A2a receptor antagonist | 0.074 0.034 CHEMBL3526547 | CHEMBL3526547 | |
| 0.036 | 0.095 | 0.076 | Adenosine A2 receptor antagonist | 0.076 0.036 CHEMBL3526547 | CHEMBL3526547 | |
| 0.029 | 0.09 | 0.066 | mTOR inhibitor | 0.066 0.024 CHEMBL3526547 | CHEMBL3526547 | |
| 0.055 | 0.116 | 0.086 | ErbB-3 antagonist | 0.086 0.053 CHEMBL3526547 | CHEMBL3526547 | |
| 0.125 | 0.188 | 0.151 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.151 0.132 CHEMBL3526547 | CHEMBL3526547 | |
| 0.11 | 0.173 | 0.148 | CF transmembrane conductance regulator agonist | 0.135 0.106 CHEMBL3526890 0.148 0.08 CHEMBL3527211 0.144 0.088 CHEMBL3526547 | CHEMBL3527211 | |
| 0.102 | 0.168 | 0.152 | Clk dual-specificity kinase inhibitor | 0.152 0.112 CHEMBL3526547 | CHEMBL3526547 | |
| 0.03 | 0.1 | 0.061 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.061 0.031 CHEMBL3526547 | CHEMBL3526547 | |
| 0.094 | 0.165 | 0.147 | CDC-like kinase 4 inhibitor | 0.147 0.103 CHEMBL3526547 | CHEMBL3526547 | |
| 0.072 | 0.143 | 0.389 | Glutamate receptor antagonist | 0.107 0.089 CHEMBL3526890 0.389 0.005 CHEMBL3526891 0.113 0.082 CHEMBL3527278 | CHEMBL3526891 | |
| 0.04 | 0.112 | 0.196 | Phosphodiesterase 4D inhibitor | 0.07 0.055 CHEMBL3527278 0.196 0.011 CHEMBL3526547 | CHEMBL3526547 | |
| 0.038 | 0.111 | 0.061 | Phosphodiesterase 1B inhibitor | 0.061 0.041 CHEMBL3526547 | CHEMBL3526547 | |
| 0.064 | 0.15 | 0.101 | RET inhibitor | 0.101 0.096 CHEMBL3527278 | CHEMBL3527278 | |
| 0.057 | 0.147 | 0.097 | Phosphodiesterase I inhibitor | 0.097 0.048 CHEMBL3526547 | CHEMBL3526547 | |
| 0.042 | 0.133 | 0.113 | Platelet activating factor beta antagonist | 0.113 0.054 CHEMBL3526547 | CHEMBL3526547 | |
| 0.036 | 0.131 | 0.109 | Cyclin B3 inhibitor | 0.109 0.025 CHEMBL3527278 0.064 0.051 CHEMBL3526547 | CHEMBL3527278 | |
| 0.025 | 0.122 | 0.046 | Diacylglycerol O-acyltransferase inhibitor | 0.046 0.042 CHEMBL3526547 | CHEMBL3526547 | |
| 0.03 | 0.127 | 0.063 | Toll-Like receptor 7 antagonist | 0.063 0.052 CHEMBL3526890 | CHEMBL3526890 | |
| 0.045 | 0.142 | 0.075 | Histamine N-methyltransferase inhibitor | 0.075 0.073 CHEMBL3526547 | CHEMBL3526547 | |
| 0.02 | 0.121 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.01 CHEMBL3526891 | CHEMBL3526891 | |
| 0.054 | 0.16 | 0.096 | c-Src kinase inhibitor | 0.096 0.093 CHEMBL3526547 | CHEMBL3526547 | |
| 0.025 | 0.132 | 0.048 | Benzodiazepine antagonist | 0.048 0.03 CHEMBL3526547 | CHEMBL3526547 | |
| 0.051 | 0.16 | 0.093 | Ephrin antagonist | 0.093 0.069 CHEMBL3526547 | CHEMBL3526547 | |
| 0.034 | 0.146 | 0.074 | 5 Hydroxytryptamine 3 agonist | 0.074 0.032 CHEMBL3526890 0.058 0.052 CHEMBL3526891 0.059 0.049 CHEMBL3526547 | CHEMBL3526890 | |
| 0.025 | 0.137 | 0.049 | Pim-2 kinase inhibitor | 0.049 0.047 CHEMBL3526890 | CHEMBL3526890 | |
| 0.034 | 0.146 | 0.118 | Rho-associated kinase inhibitor | 0.118 0.027 CHEMBL3526890 | CHEMBL3526890 | |
| 0.07 | 0.188 | 0.193 | CDK3/cyclin E inhibitor | 0.193 0.008 CHEMBL3526548 0.129 0.044 CHEMBL3527278 | CHEMBL3526548 | |
| 0.023 | 0.142 | 0.22 | GABA receptor antagonist | 0.22 0.005 CHEMBL3526547 | CHEMBL3526547 | |
| 0.022 | 0.142 | 0.111 | Phosphodiesterase 4C inhibitor | 0.111 0.012 CHEMBL3526547 | CHEMBL3526547 | |
| 0.026 | 0.152 | 0.061 | Cyclin B1 inhibitor | 0.061 0.042 CHEMBL3527278 | CHEMBL3527278 | |
| 0.062 | 0.192 | 0.093 | T cell inhibitor | 0.093 0.033 CHEMBL3526547 | CHEMBL3526547 | |
| 0.054 | 0.188 | 0.094 | mTOR complex 2 inhibitor | 0.077 0.076 CHEMBL3526890 0.094 0.04 CHEMBL3526547 | CHEMBL3526547 | |
| 0.035 | 0.17 | 0.23 | Glutamate (mGluR) antagonist | 0.073 0.057 CHEMBL3526890 0.23 0.008 CHEMBL3526891 | CHEMBL3526891 | |
| 0.023 | 0.16 | 0.051 | Cyclin B inhibitor | 0.051 0.045 CHEMBL3527278 | CHEMBL3527278 | |
| 0.023 | 0.162 | 0.072 | Potassium channel small-conductance Ca-activated blocker | 0.072 0.012 CHEMBL3526547 | CHEMBL3526547 | |
| 0.034 | 0.175 | 0.133 | Rho-associated kinase II inhibitor | 0.133 0.021 CHEMBL3526890 | CHEMBL3526890 | |
| 0.021 | 0.164 | 0.227 | GABA A receptor antagonist | 0.227 0.005 CHEMBL3526547 | CHEMBL3526547 | |
| 0.043 | 0.187 | 0.121 | Glycogen synthase kinase-3 beta inhibitor | 0.121 0.06 CHEMBL3527278 | CHEMBL3527278 | |
| 0.021 | 0.17 | 0.104 | Purinergic P2X2 antagonist | 0.104 0.028 CHEMBL3527278 | CHEMBL3527278 | |
| 0.146 | 0.297 | 0.355 | GABA C receptor rho-3 antagonist | 0.211 0.194 CHEMBL3527278 0.355 0.083 CHEMBL3526547 | CHEMBL3526547 | |
| 0.079 | 0.234 | 0.165 | Heat shock protein 90 alpha antagonist | 0.165 0.073 CHEMBL3527278 | CHEMBL3527278 | |
| 0.024 | 0.181 | 0.087 | Phosphodiesterase III inhibitor | 0.087 0.03 CHEMBL3526547 | CHEMBL3526547 | |
| 0.042 | 0.202 | 0.133 | Glycogen synthase kinase-3 inhibitor | 0.133 0.053 CHEMBL3527278 | CHEMBL3527278 | |
| 0.046 | 0.212 | 0.137 | 5 Hydroxytryptamine 3A agonist | 0.137 0.043 CHEMBL3526547 | CHEMBL3526547 | |
| 0.03 | 0.201 | 0.077 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.077 0.075 CHEMBL3527278 | CHEMBL3527278 | |
| 0.047 | 0.227 | 0.143 | NADH dehydrogenase inhibitor | 0.093 0.052 CHEMBL3526548 0.105 0.039 CHEMBL3526891 0.143 0.019 CHEMBL3527211 0.093 0.053 CHEMBL3526547 | CHEMBL3527211 | |
| 0.018 | 0.2 | 0.052 | EphB4 antagonist | 0.052 0.047 CHEMBL3526547 | CHEMBL3526547 | |
| 0.078 | 0.261 | 0.35 | Aldehyde oxidase inhibitor | 0.188 0.111 CHEMBL3526891 0.35 0.055 CHEMBL3526547 | CHEMBL3526547 | |
| 0.119 | 0.309 | 0.256 | Peptidyltransferase inhibitor | 0.184 0.122 CHEMBL3526548 0.256 0.047 CHEMBL3527211 | CHEMBL3527211 | |
| 0.035 | 0.226 | 0.097 | Platelet activating factor antagonist | 0.097 0.081 CHEMBL3526547 | CHEMBL3526547 | |
| 0.043 | 0.236 | 0.218 | GABA receptor agonist | 0.218 0.014 CHEMBL3526547 | CHEMBL3526547 | |
| 0.106 | 0.302 | 0.214 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.205 0.068 CHEMBL3526548 0.159 0.128 CHEMBL3527211 0.214 0.061 CHEMBL3526547 | CHEMBL3526547 | |
| 0.08 | 0.279 | 0.268 | Antipruritic | 0.164 0.079 CHEMBL3526890 0.268 0.02 CHEMBL3526891 | CHEMBL3526891 | |
| 0.021 | 0.222 | 0.083 | Phosphodiesterase 5A inhibitor | 0.083 0.037 CHEMBL3526547 | CHEMBL3526547 | |
| 0.005 | 0.207 | 0.023 | Aggrecanase 2 inhibitor | 0.023 0.014 CHEMBL3526891 | CHEMBL3526891 | |
| 0.007 | 0.21 | 0.028 | Protocollagen prolyl hydroxylase inhibitor | 0.028 0.018 CHEMBL3526547 | CHEMBL3526547 | |
| 0.019 | 0.233 | 0.082 | Phosphodiesterase V inhibitor | 0.082 0.039 CHEMBL3526547 | CHEMBL3526547 | |
| 0.02 | 0.242 | 0.094 | CDK2/cyclin E2 inhibitor | 0.064 0.057 CHEMBL3526548 0.094 0.03 CHEMBL3527278 | CHEMBL3527278 | |
| 0.068 | 0.297 | 0.152 | Death-associated protein kinase 3 inhibitor | 0.152 0.12 CHEMBL3527278 | CHEMBL3527278 | |
| 0.091 | 0.321 | 0.362 | Death-associated protein kinase 2 inhibitor | 0.362 0.004 CHEMBL3527278 | CHEMBL3527278 | |
| 0.027 | 0.265 | 0.071 | Acetylcholine M3 receptor agonist | 0.071 0.07 CHEMBL3527278 | CHEMBL3527278 | |
| 0.052 | 0.292 | 0.127 | Interleukin 12 antagonist | 0.127 0.023 CHEMBL3526547 | CHEMBL3526547 | |
| 0.083 | 0.327 | 0.29 | Cyclic AMP phosphodiesterase inhibitor | 0.29 0.046 CHEMBL3526548 0.228 0.075 CHEMBL3527278 0.226 0.077 CHEMBL3526547 | CHEMBL3526548 | |
| 0.008 | 0.255 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.015 CHEMBL3527211 | CHEMBL3527211 | |
| 0.016 | 0.265 | 0.056 | Antibiotic Aminoglycoside-like | 0.04 0.021 CHEMBL3526548 0.056 0.01 CHEMBL3527211 | CHEMBL3527211 | |
| 0.015 | 0.27 | 0.095 | Phosphodiesterase 4B inhibitor | 0.095 0.027 CHEMBL3526547 | CHEMBL3526547 | |
| 0.037 | 0.295 | 0.112 | Toll-Like receptor 9 antagonist | 0.112 0.095 CHEMBL3526547 | CHEMBL3526547 | |
| 0.034 | 0.294 | 0.111 | Protein kinase C gamma inhibitor | 0.111 0.062 CHEMBL3526890 | CHEMBL3526890 | |
| 0.034 | 0.294 | 0.075 | MAP kinase kinase 8 inhibitor | 0.075 0.039 CHEMBL3527278 | CHEMBL3527278 | |
| 0.031 | 0.291 | 0.119 | GABA A receptor agonist | 0.119 0.024 CHEMBL3526547 | CHEMBL3526547 | |
| 0.151 | 0.414 | 0.557 | Antiinflammatory | 0.391 0.144 CHEMBL3526548 0.557 0.066 CHEMBL3527211 | CHEMBL3527211 | |
| 0.016 | 0.285 | 0.091 | Glutamate (mGluR8) antagonist | 0.042 0.015 CHEMBL3526890 0.091 0.003 CHEMBL3526891 | CHEMBL3526891 | |
| 0.037 | 0.313 | 0.106 | Sodium channel blocker | 0.106 0.104 CHEMBL3526890 | CHEMBL3526890 | |
| 0.053 | 0.334 | 0.163 | Aurora-C kinase inhibitor | 0.163 0.038 CHEMBL3527278 | CHEMBL3527278 | |
| 0.031 | 0.316 | 0.078 | Phosphodiesterase VI inhibitor | 0.078 0.044 CHEMBL3526547 | CHEMBL3526547 | |
| 0.054 | 0.352 | 0.264 | Interleukin agonist | 0.264 0.069 CHEMBL3527211 | CHEMBL3527211 | |
| 0.005 | 0.303 | 0.178 | Glutamate (mGluR2) agonist | 0.028 0.027 CHEMBL3526890 0.178 0.004 CHEMBL3526891 | CHEMBL3526891 | |
| 0.097 | 0.397 | 0.207 | Toll-Like receptor 7 agonist | 0.207 0.193 CHEMBL3526890 | CHEMBL3526890 | |
| 0.008 | 0.311 | 0.207 | Glutamate (mGluR group II) agonist | 0.032 0.027 CHEMBL3526890 0.207 0.004 CHEMBL3526891 | CHEMBL3526891 | |
| 0.061 | 0.364 | 0.132 | DNA repair enzyme inhibitor | 0.132 0.051 CHEMBL3527211 | CHEMBL3527211 | |
| 0.014 | 0.319 | 0.145 | Phosphodiesterase IV inhibitor | 0.076 0.066 CHEMBL3527278 0.145 0.024 CHEMBL3526547 | CHEMBL3526547 | |
| 0.098 | 0.404 | 0.136 | Heat shock protein 70 antagonist | 0.129 0.126 CHEMBL3526891 0.136 0.093 CHEMBL3526547 | CHEMBL3526547 | |
| 0.014 | 0.323 | 0.052 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.052 0.045 CHEMBL3527211 | CHEMBL3527211 | |
| 0.046 | 0.356 | 0.093 | Adenylate kinase inhibitor | 0.093 0.081 CHEMBL3526891 | CHEMBL3526891 | |
| 0.093 | 0.407 | 0.202 | Toll-Like receptor agonist | 0.202 0.199 CHEMBL3526890 | CHEMBL3526890 | |
| 0.065 | 0.391 | 0.177 | Focal adhesion kinase 2 inhibitor | 0.177 0.091 CHEMBL3526547 | CHEMBL3526547 | |
| 0.019 | 0.35 | 0.039 | Glucagon-like peptide 1 receptor antagonist | 0.039 0.028 CHEMBL3526891 | CHEMBL3526891 | |
| 0.084 | 0.416 | 0.214 | Nootropic | 0.214 0.141 CHEMBL3526890 | CHEMBL3526890 | |
| 0.017 | 0.354 | 0.118 | MAP kinase kinase 10 inhibitor | 0.118 0.015 CHEMBL3527278 | CHEMBL3527278 | |
| 0.021 | 0.36 | 0.091 | Glucosylceramidase inhibitor | 0.091 0.011 CHEMBL3526548 | CHEMBL3526548 | |
| 0.056 | 0.396 | 0.155 | Pregnane X receptor agonist | 0.155 0.045 CHEMBL3526547 | CHEMBL3526547 | |
| 0.011 | 0.358 | 0.093 | NMDA receptor antagonist | 0.093 0.051 CHEMBL3526891 | CHEMBL3526891 | |
| 0.021 | 0.37 | 0.15 | Ca(v)2.2 blocker | 0.15 0.029 CHEMBL3527278 | CHEMBL3527278 | |
| 0.048 | 0.398 | 0.192 | Hexokinase inhibitor | 0.142 0.088 CHEMBL3526891 0.192 0.04 CHEMBL3527211 0.155 0.073 CHEMBL3526547 | CHEMBL3527211 | |
| 0.01 | 0.363 | 0.043 | Adenosine deaminase inhibitor | 0.043 0.037 CHEMBL3527211 | CHEMBL3527211 | |
| 0.012 | 0.372 | 0.068 | MAP kinase 10 inhibitor | 0.068 0.067 CHEMBL3527278 | CHEMBL3527278 | |
| 0.043 | 0.409 | 0.206 | Prostaglandin dehydrogenase inhibitor | 0.206 0.152 CHEMBL3526547 | CHEMBL3526547 | |
| 0.013 | 0.38 | 0.127 | Acid-sensing ion channel blocker | 0.127 0.003 CHEMBL3527278 | CHEMBL3527278 | |
| 0.004 | 0.373 | 0.051 | Glutamate (mGluR group II) antagonist | 0.051 0.015 CHEMBL3526891 | CHEMBL3526891 | |
| 0.003 | 0.375 | 0.029 | Glutamate (mGluR2) antagonist | 0.029 0.022 CHEMBL3526891 | CHEMBL3526891 | |
| 0.033 | 0.416 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | 0.096 0.062 CHEMBL3527278 | CHEMBL3527278 | |
| 0.024 | 0.418 | 0.157 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.157 0.125 CHEMBL3527278 | CHEMBL3527278 | |
| 0.024 | 0.419 | 0.151 | Dyrk kinase inhibitor | 0.151 0.135 CHEMBL3527278 | CHEMBL3527278 | |
| 0.007 | 0.409 | 0.334 | Glutamate (mGluR) agonist | 0.334 0.005 CHEMBL3526891 | CHEMBL3526891 | |
| 0.005 | 0.423 | 0.053 | Opioid kappa receptor agonist | 0.053 0.022 CHEMBL3526891 | CHEMBL3526891 | |
| 0.029 | 0.463 | 0.114 | DNA polymerase I inhibitor | 0.114 0.073 CHEMBL3526548 0.114 0.073 CHEMBL3527211 | CHEMBL3527211 | |
| 0.026 | 0.479 | 0.154 | Acetylcholine M1 receptor antagonist | 0.154 0.07 CHEMBL3527278 | CHEMBL3527278 | |
| 0.041 | 0.494 | 0.393 | DNA synthesis inhibitor | 0.393 0.022 CHEMBL3526548 0.294 0.046 CHEMBL3526891 0.281 0.05 CHEMBL3527211 | CHEMBL3526548 | |
| 0.006 | 0.474 | 0.083 | 5 Hydroxytryptamine 1F antagonist | 0.083 0.041 CHEMBL3527278 | CHEMBL3527278 | |
| 0.005 | 0.485 | 0.066 | Glutamate (mGluR3) antagonist | 0.066 0.007 CHEMBL3526891 | CHEMBL3526891 | |
| 0.021 | 0.502 | 0.063 | Glutamate (mGluR6) antagonist | 0.063 0.057 CHEMBL3526891 | CHEMBL3526891 | |
| 0.069 | 0.553 | 0.238 | Calcium channel activator | 0.238 0.162 CHEMBL3526547 | CHEMBL3526547 | |
| 0.01 | 0.495 | 0.052 | Protein 50S ribosomal subunit inhibitor | 0.052 0.038 CHEMBL3527211 | CHEMBL3527211 | |
| 0.033 | 0.523 | 0.139 | Platelet adhesion inhibitor | 0.139 0.119 CHEMBL3527211 | CHEMBL3527211 | |
| 0.013 | 0.519 | 0.045 | Glutamate (mGluR4) antagonist | 0.045 0.028 CHEMBL3526891 | CHEMBL3526891 | |
| 0.005 | 0.516 | 0.068 | Phosphofructokinase-1 inhibitor | 0.068 0.05 CHEMBL3527211 | CHEMBL3527211 | |
| 0.079 | 0.599 | 0.356 | Interleukin 2 agonist | 0.245 0.125 CHEMBL3526548 0.356 0.043 CHEMBL3527211 | CHEMBL3527211 | |
| 0.038 | 0.576 | 0.281 | Immunosuppressant | 0.231 0.165 CHEMBL3526548 0.263 0.138 CHEMBL3526891 0.281 0.127 CHEMBL3527211 | CHEMBL3527211 | |
| 0.003 | 0.549 | 0.043 | Phosphorylase inhibitor | 0.043 0.035 CHEMBL3526548 | CHEMBL3526548 | |
| 0.005 | 0.597 | 0.172 | Selectin antagonist | 0.085 0.034 CHEMBL3526548 0.172 0.015 CHEMBL3527211 | CHEMBL3527211 | |
| 0.014 | 0.623 | 0.326 | Immunostimulant | 0.2 0.12 CHEMBL3526548 0.326 0.071 CHEMBL3527211 | CHEMBL3527211 | |
| 0.009 | 0.625 | 0.092 | Topoisomerase I inhibitor | 0.092 0.078 CHEMBL3527211 | CHEMBL3527211 | |
| 0.003 | 0.621 | 0.032 | Dipeptidyl peptidase I inhibitor | 0.032 0.02 CHEMBL3526890 | CHEMBL3526890 | |
| 0.004 | 0.634 | 0.022 | Histone deacetylase 6 inhibitor | 0.022 0.021 CHEMBL3527277 | CHEMBL3527277 | |
| 0.008 | 0.652 | 0.04 | Glutamate (mGluR group III) antagonist | 0.04 0.038 CHEMBL3526891 | CHEMBL3526891 | |
| 0.022 | 0.706 | 0.397 | Antibacterial | 0.397 0.078 CHEMBL3527211 | CHEMBL3527211 | |
| 0.004 | 0.698 | 0.026 | Histone deacetylase class II inhibitor | 0.026 0.023 CHEMBL3527277 | CHEMBL3527277 | |
| 0.01 | 0.709 | 0.17 | Free radical scavenger | 0.17 0.124 CHEMBL3527211 | CHEMBL3527211 | |
| 0.04 | 0.761 | 0.196 | Lipocortins synthesis antagonist | 0.196 0.059 CHEMBL3527278 | CHEMBL3527278 | |
| 0.005 | 0.73 | 0.052 | Alpha-mannosidase inhibitor | 0.052 0.04 CHEMBL3527211 | CHEMBL3527211 | |
| 0.003 | 0.748 | 0.041 | Mannosidase inhibitor | 0.041 0.038 CHEMBL3527211 | CHEMBL3527211 | |
| 0.023 | 0.785 | 0.086 | Transcription factor NF kappa B stimulant | 0.086 0.058 CHEMBL3527211 | CHEMBL3527211 | |
| 0.011 | 0.774 | 0.409 | Angiogenesis stimulant | 0.409 0.02 CHEMBL3527211 | CHEMBL3527211 | |
| 0.027 | 0.815 | 0.123 | NOS3 expression enhancer | 0.123 0.109 CHEMBL3527211 | CHEMBL3527211 | |
| 0.007 | 0.797 | 0.194 | Antioxidant | 0.194 0.119 CHEMBL3527211 | CHEMBL3527211 | |
| 0.015 | 0.809 | 0.1 | Toll-Like receptor 4 antagonist | 0.1 0.069 CHEMBL3527211 | CHEMBL3527211 | |
| 0.003 | 0.803 | 0.116 | Antineoplastic antibiotic | 0.116 0.04 CHEMBL3527211 | CHEMBL3527211 | |
| 0.02 | 0.839 | 0.186 | Hepatoprotectant | 0.186 0.074 CHEMBL3527211 | CHEMBL3527211 | |
| 0.012 | 0.875 | 0.198 | Hypoglycemic | 0.198 0.115 CHEMBL3527211 | CHEMBL3527211 | |
| 0.02 | 0.893 | 0.241 | Apoptosis antagonist | 0.241 0.137 CHEMBL3527211 | CHEMBL3527211 | |
| 0.005 | 0.901 | 0.137 | Nitric oxide antagonist | 0.137 0.109 CHEMBL3527211 | CHEMBL3527211 | |
| 0.008 | 0.913 | 0.245 | Apoptosis agonist | 0.245 0.22 CHEMBL3527211 | CHEMBL3527211 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |